Emtricitabine/rilpivirine/tenofovir alafenamide Drug Interactions
Currently displaying 213 drugs known to have a major interaction with emtricitabine / rilpivirine / tenofovir alafenamide.
- 213 major drug interactions
- 325 moderate drug interactions
- 2 minor drug interactions
Major interactions with emtricitabine / rilpivirine / tenofovir alafenamide
Note: Showing generic names only.
A
- acyclovir
- adagrasib
- adefovir
- aldesleukin
- amikacin
- amikacin liposome
- amiodarone
- amisulpride
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- apalutamide
- arsenic trioxide
- atidarsagene autotemcel
B
- bacitracin
- balsalazide
- bedaquiline
- bepridil
- betibeglogene autotemcel
- botulism immune globulin
- bromfenac
C
- cabozantinib
- capreomycin
- carbamazepine
- carboplatin
- celecoxib
- ceritinib
- chloroquine
- cidofovir
- cimetidine
- cisapride
- cisplatin
- citalopram
- clofarabine
- clozapine
- colistimethate
- crizotinib
- cyclophosphamide
- cyclosporine
- cytomegalovirus immune globulin
D
- deferasirox
- deferoxamine
- dexamethasone
- dexlansoprazole
- diatrizoate
- diclofenac
- didanosine
- diflunisal
- disopyramide
- dofetilide
- dolasetron
- dronedarone
- droperidol
E
- edetate calcium disodium
- edetate disodium (edta)
- efavirenz
- elivaldogene autotemcel
- enzalutamide
- escitalopram
- esomeprazole
- etidronate
- etodolac
- etrasimod
- everolimus
F
G
H
I
- ibandronate
- ibuprofen
- ibutilide
- ifosfamide
- iloperidone
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- inotersen
- iobenguane I 131
- iodamide
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
- ivabradine
- ivosidenib
K
L
- lamivudine
- lansoprazole
- lefamulin
- leflunomide
- levoketoconazole
- levomethadyl acetate
- lifileucel
- lithium
- lomitapide
- lorlatinib
- lovotibeglogene autotemcel
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
M
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- mesoridazine
- methadone
- methotrexate
- methoxyflurane
- metrizamide
- mifepristone
- mipomersen
- mitotane
- mobocertinib
- modafinil
- moxetumomab pasudotox
- moxifloxacin
N
O
P
- pacritinib
- pamidronate
- panobinostat
- pantoprazole
- papaverine
- pasireotide
- penicillamine
- pentamidine
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pimozide
- piroxicam
- plazomicin
- polymyxin b
- ponesimod
- primidone
- procainamide
Q
R
- rabeprazole
- ranitidine
- ranitidine bismuth citrate
- respiratory syncytial virus immune globulin
- rho (d) immune globulin
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rofecoxib
S
- salsalate
- saquinavir
- selpercatinib
- siponimod
- sirolimus
- sotalol
- sparfloxacin
- st. john's wort
- streptomycin
- streptozocin
- sulfasalazine
- sulindac
T
- tacrolimus
- telavancin
- temsirolimus
- teriflunomide
- thioridazine
- tipranavir
- tobramycin
- tolmetin
- toremifene
V
Z
Emtricitabine/rilpivirine/tenofovir alafenamide alcohol/food interactions
There are 2 alcohol/food interactions with emtricitabine / rilpivirine / tenofovir alafenamide.
Emtricitabine/rilpivirine/tenofovir alafenamide disease interactions
There are 10 disease interactions with emtricitabine / rilpivirine / tenofovir alafenamide which include:
- hepatitis B
- hepatotoxicity
- hemodialysis
- renal dysfunction
- depression
- liver impairment
- renal impairment
- bone toxicity
- liver disease
- renal dysfunction
More about emtricitabine / rilpivirine / tenofovir alafenamide
- emtricitabine/rilpivirine/tenofovir alafenamide consumer information
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.